Final-Program-ATS-2023-AP.vp

114

SUNDAY • MAY 21

2:51 A Supervised Machine-learned Algorithm to IDENTIFY PH in Patients With New Onset Symptoms/ C.R. Bridges, Washington, DC 3:03 Cytokines as Prognostic Biomarkers in Pulmonary Arterial Hypertension/ A. Boucly, London, United Kingdom 3:15 Complement Cascade Peptide Levels in the Peripheral Circulation of PAH Patients Are Related to Hemodynamic Measures of Vascular Function/ V.O. Kheyfets, Aurora, CO 3:27 Mitochondrial Dysfunction Across Pulmonary Vascular Diseases/ S.Y. Farha, Cleveland, OH 3:39 Compartment-specific Remodeling of End-stage Chronic Obstructive Pulmonary Disease Patients With Severe Pulmonary Hypertension Based on Histological Lung Tissue Samples/ K. Zeder, Graz, Austria 3:51 Metabolites of the Kynurenine Pathway Are Significantly Altered in Systemic Sclerosis Associated PAH Compared to Other Subgroups of PAH/ N. Wallace, San Diego, CA 4:03 Pulmonary Vascular Pruning in Severe Pulmonary Hypertension Associated With Chronic Lung Diseases/ A.R. Garcia, Barcelona, Spain

2:51 End-of-Life Decision Making and Symptoms After a Loved One’s Cardiac Arrest: A Qualitative Descriptive Study/ C.E. Deforge, New York, NY 3:03 Development of a Digital ICU Diary Intervention Prototype for Survivors of Critical Illness Requiring Extracorporeal Membrane Oxygenation (ECMO)/ K. Knudson, Milwaukee, WI Self-management Responsibility During Healthcare Transition/ K. South, New York, NY 3:27 Effects of a Web-based Multiple Component Mindfulness Meditation for Pulmonary Hypertension (MMPH) Program on Symptoms and Health-related Quality of Life: A Pilot Randomized Controlled Trial/ T.T. Von Visger, Buffalo, NY 3:39 A Randomized Clinical Trial to Test a Mobile Application That Supports Family Caregiver Participation in Patient Care in the Intensive Care Unit/ B.D. Hetland, Omaha, NE 3:51 A Pilot Randomized Trial of a Videoconferencing-based Communication Training Program With Group Coaching for Intensive Care Unit Nurses/ J. Choi, Seoul, Korea, Republic of 3:15 Navigating the Transfer of Cystic Fibrosis

CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

A97

RISE OF THE MACHINES: -OMICS AND COMPUTATIONAL BIOLOGY IN PULMONARY HYPERTENSION

A98

HOST VS. BUG

2:15 p.m. - 4:15 p.m.

Walter E. Washington Convention Center Room 202 A (Level 2)

2:15 p.m. - 4:15 p.m.

Walter E. Washington Convention Center Room 150 A-B (Street Level)

Chairing: J. Keane, MD, Dublin, Ireland

Chairing: C.J. Rhodes, PhD, London, United Kingdom D. Valdez-Jasso, PhD, La Jolla, CA F.N. Rahaghi, MD, PhD, Boston, MA C. Simpson, MD, Baltimore, MD Oral Presentations: 2:15 Fatty Acid Dysregulation Identifies Right Ventricular Dysfunction in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Metabolomic Analysis in the Pulmonary Vascular Disease Phenomics (PVDOMICS) Cohort/ S. Chung, New York, NY 2:27 Using an Unsupervised Learning Ensemble to Identify and Evaluate PAH Immune Phenotypes Longitudinally During Disease Progression/ A. Sweatt, Stanford, CA 2:39 Distinct Proteomic Signatures Are Associated With Right Ventricular Vulnerability and Outcomes in Pulmonary Arterial Hypertension/ H. Pi, Seattle, WA

K. Traber, MD, PhD, ATSF, Boston, MA J. Pantaleon-Garcia, MD, Houston, TX

Oral Presentations: 2:15 Pulmonary Surfactant Phospholipids Antagonize Infection and Replication of SARS-CoV-2 and Its Variants/ J. Loeffler, Denver, CO 2:27 The Anti-inflammatory Club Cell Protein 16 Is Decreased in Human Airways After Intrabronchial Lipopolysaccharide (LPS) Exposure/ E.I. Cardenas, Stockholm, Sweden 2:39 Murine Host Response to Typical and Atypical Pneumonia/ M.S. Mccravy, Durham, NC 2:51 A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Bronchiectasis Patient

Neutrophil-Mediated Killing of Pseudomonas Aeruginosa/ M.B. Long, Dundee, United Kingdom

ATS 2023 • Washington, DC